Section Arrow
VERV.NASDAQ
- Verve Therapeutics
Quotes are at least 15-min delayed:2024/12/24 12:33 EST
Last
 5.79
-0.11 (-1.86%)
Day High 
5.97 
Prev. Close
5.9 
1-M High
7.66 
Volume 
368.58K 
Bid
5.78
Ask
5.79
Day Low
5.63 
Open
5.93 
1-M Low
4.88 
Market Cap 
499.52M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 5.79 
20-SMA 6.02 
50-SMA 5.79 
52-W High 19.34 
52-W Low 4.305 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.46/-2.83
Enterprise Value
564.23M
Balance Sheet
Book Value Per Share
6.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
11.76M
Operating Revenue Per Share
0.09
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.39-0.0131-3.25%-- 
CMNDClearmind Medicine1.622+0.402+32.95%0.16PE
CEROCERo Therapeutics Holdings0.0597+0.0092+18.22%-- 
RXRXRecursion Pharmaceuticals7.2+0.21+3.00%-- 
CDTConduit Pharmaceuticals0.059101+0.004601+8.44%-- 
Quotes are at least 15-min delayed:2024/12/24 12:33 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.